P2 Receptor Signaling in Neurons and Glial Cells of the Central Nervous System

Advances in Pharmacology

Volumn 61, Issue , 2011, Pages 441-493

  Köles, Laszlo ^a,b   Leichsenring, Anna ^a   Rubini, Patrizia ^a   Illes, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Functional role; Glial cells; Neuron glia interaction; Neurons; P2 receptors; Pharmacological characterization

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; ION CHANNEL; NUCLEOTIDE; PURINE; PURINERGIC P2X RECEPTOR; PYRIMIDINE NUCLEOTIDE;

ASTROCYTE; BOOK; CARBOXY TERMINAL SEQUENCE; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; GLIA CELL; MAMMAL; MICROGLIA; MOLECULE; NERVE CELL; NERVE DEGENERATION; NERVE ENDING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; OLIGODENDROGLIA; OSCILLATION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 79955945040     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385526-8.00014-X     Document Type: Chapter

References (330)

1. Abbracchio M.P., Brambilla R., Ceruti S., Cattabeni F. Signalling mechanisms involved in P2Y receptor-mediated reactive astrogliosis. Progress in Brain Research 1999, 120:333-342.
2. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., et al. International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharmacological Reviews 2006, 58:281-341.
3. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signalling in the nervous system: An overview. Trends in Neurosciences 2009, 32:19-29.
4. Abbracchio M.P., Saffrey M.J., Höpker V., Burnstock G. Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum. Neuroscience 1994, 59:67-76.
5. Agresti C., Meomartini M.E., Amadio S., Ambrosini E., Volonté C., Aloisi F., et al. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: Involvement of metabotropic P2 receptors. Brain Research. Brain Research Reviews 2005, 48:157-165.
6. Aihara H., Fujiwara S., Mizuta I., Tada H., Kanno T., Tozaki H., et al. Adenosine triphosphate accelerates recovery from hypoxic/hypoglycemic perturbation of guinea pig hippocampal neurotransmission via a P2 receptor. Brain Research 2002, 952:31-37.
7. Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., et al. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 2002, 42:489-501.
8. Andó R.D., Méhész B., Gyires K., Illes P., Sperlágh B. A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain. British Journal of Pharmacology 2010, 159:1106-1117.
9. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses: Glia, the unacknowledged partner. Trends in Neurosciences 1999, 22:208-215.
10. 1+2 receptor subtypes. Journal of Molecular Biology 2004, 342:333-343.
11. 1 subunit. Journal of Neurochemistry 2010, 113:1676-1684.
12. Avignone E., Ulmann L., Levavasseur F., Rassendren F., Audinat E. Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. The Journal of Neuroscience 2008, 28:9133-9144.
13. 7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes. International Journal of Immunopathology and Pharmacology 2005, 18:417-430.
14. 3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. The Journal of Neuroscience 2002, 22:8139-8147.
15. 7 as a susceptibility gene to bipolar affective disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:374-382.
16. Bardoni R., Goldstein P.A., Lee C.J., Gu J.G., MacDermott A.B. ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. The Journal of Neuroscience 1997, 17:5297-5304.
17. 7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders. Behavioural Brain Research 2009, 198:83-90.
18. Bennett G.C., Boarder M.R. The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices. British Journal of Pharmacology 2000, 131:617-623.
19. Bianco F., Fumagalli M., Pravettoni E., D'Ambrosi N., Volonte C., Matteoli M., et al. Pathophysiological roles of extracellular nucleotides in glial cells: Differential expression of purinergic receptors in resting and activated microglia. Brain Research. Brain Research Reviews 2005, 48:144-156.
20. 5 receptor. Molecular Pharmacology 2003, 63:1407-1416.
21. 4 receptors studied with an ectodomain antibody. Cell and Tissue Research 2003, 313:159-165.
22. Bodin P., Burnstock G. Purinergic signalling: ATP release. Neurochemical Research 2001, 26:959-969.
23. Boehm S. ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. The Journal of Neuroscience 1999, 19:737-746.
24. 2+ channels in rat dorsal root ganglion neurons. Synapse 2003, 47:159-161.
25. Boucsein C., Zacharias R., Färber K., Pavlovic S., Hanisch U.K., Kettenmann H. Purinergic receptors on microglial cells: Functional expression in acute brain slices and modulation of microglial activation in vitro. The European Journal of Neuroscience 2003, 17:2267-2276.
26. 2 ATP-gated channels. The Journal of Biological Chemistry 2000, 275:10190-10195.
27. Boué-Grabot E., Barajas-López C., Chakfe Y., Blais D., Bélanger D., Emerit M.B., et al. Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels. Journal of Neuroscience 2003, 23:1246-1253.
28. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nature Reviews. Neuroscience 2001, 2:274-286.
29. Bowser D.N., Khakh B.S. ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks. The Journal of Neuroscience 2004, 24:8606-8620.
30. Bowser D.N., Khakh B.S. Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes. The Journal of General Physiology 2007, 129:485-491.
31. Brake A.J., Wagenbach M.J., Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 1994, 371:519-523.
32. Brambilla R., Neary J.T., Cattabeni F., Cottini L., D'Ippolito G., Schiller P.C., et al. Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. Journal of Neurochemistry 2002, 83:1285-1296.
33. 1/2 receptors show a novel sensitivity to extracellular pH. The Journal of Pharmacology and Experimental Therapeutics 2002, 300:673-680.
34. 3 receptors is unlikely to involve direct receptor phosphorylation. Biochimica et Biophysica Acta 2007, 1773:166-175.
35. Buell G., Lewis C., Collo G., North R.A., Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. The EMBO Journal 1996, 15:55-62.
36. Burnstock G. Purinergic nerves. Pharmacological Reviews 1972, 24:509-581.
37. Burnstock G. A unifying purinergic hypothesis for the initiation of pain. Lancet 1996, 347:1604-1605.
38. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiological Reviews 2007, 87:659-797.
39. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor?. General Pharmacology 1985, 16:433-440.
40. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. International Review of Cytology 2004, 240:31-304.
41. 13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. Journal of Neurochemistry 2009, 110:879-889.
42. 7 receptor antagonists for chronic inflammation and pain. Purinergic Signalling 2009, 5:63-73.
43. 2/3 antagonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters 2009, 19:1628-1631.
44. 4 receptor during hypoglycemia: Cross talk with the ionotropic NMDAR1 receptor. Experimental Cell Research 2004, 300:149-158.
45. 4 receptor and ischemic cell death prevention by P2 antagonists. Neuroscience 2003, 120:85-98.
46. Cavaliere F., Sancesario G., Bernardi G., Volonté C. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: Role of P2 and NGFRp75 receptors. Journal of Neurochemistry 2002, 83:1129-1138.
47. Ceruti S., Villa G., Genovese T., Mazzon E., Longhi R., Rosa P., et al. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain 2009, 132:2206-2218.
48. Chen C.C., Akopian A.N., Sivilotti L., Colquhoun D., Burnstock G., Wood J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 1995, 77:428-431.
49. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
50. Cheung K.K., Chan W.Y., Burnstock G. Expression of P2X purinoceptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures. Neuroscience 2005, 133:937-945.
51. Cheung K.K., Ryten M., Burnstock G. Abundant and dynamic expression of G protein-coupled P2Y receptors in mammalian development. Developmental Dynamics 2003, 228:254-266.
52. Chizh B.A., Illes P. P2X receptors and nociception. Pharmacological Reviews 2001, 53:553-568.
53. Chorna N.E., Santiago-Pérez L.I., Erb L., Seye C.I., Neary J.T., Sun G.Y., et al. P2Y receptors activate neuroprotective mechanisms in astrocytic cells. Journal of Neurochemistry 2004, 91:119-132.
54. Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. The EMBO Journal 2006, 25:4615-4627.
55. Ciccarelli R., Ballerini P., Sabatino G., Rathbone M.P., D'Onofrio M., Caciagli F., et al. Involvement of astrocytes in purine-mediated reparative processes in the brain. International Journal of Developmental Neuroscience 2001, 19:395-414.
56. 2 receptor subunit in mediating multiple sensory effects of ATP. Journal de Physiologie 2005, 567:621-639.
57. Coco S., Calegari F., Pravettoni E., Pozzi D., Taverna E., Rosa P., et al. Storage and release of ATP from astrocytes in culture. The Journal of Biological Chemistry 2003, 278:1354-1362.
58. 2 purinoreceptor protein in hypothalamic neurons associated with the regulation of food intake. Neuroscience 2010, 171:62-78.
59. Communi D., Govaerts C., Parmentier M., Boeynaems J.M. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. The Journal of Biological Chemistry 1997, 272:31969-31973.
60. Cook S.P., McCleskey E.W. Cell damage excites nociceptors through release of cytosolic ATP. Pain 2002, 95:41-47.
61. Cunha R.A., Ribeiro J.A. ATP as a presynaptic modulator. Life Sciences 2000, 68:119-137.
62. 3 H]acetylcholine from the hippocampus and cerebral cortex of the rat: Role of the ectonucleotidases. The European Journal of Neuroscience 1994, 6:33-42.
63. 2 receptor mRNA in astrocytes cultured from rat brain. International Journal of Immunopathology and Pharmacology 2007, 20:301-316.
64. 6 receptor architecture in naive and transfected neuronal systems. Biochimica et Biophysica Acta 2007, 1768:1592-1599.
65. 4 receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells. Purinergic Signalling 2006, 2:575-582.
66. D'Ambrosi N., Murra B., Cavaliere F., Amadio S., Bernardi G., Burnstock G., et al. Interaction between ATP and nerve growth factor signaling in the survival and neuritic outgrowth from PC12 cells. Neuroscience 2001, 108:527-534.
67. Dani J.W., Chernjavsky A., Smith S.J. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron 1992, 8:429-440.
68. De Lorenzo S., Veggetti M., Muchnik S., Losavio A. Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction. Neuroscience 2006, 142:71-85.
69. 7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. The Journal of Neuroscience 2001, 21:7143-7152.
70. 3 subunits. Neuroscience Letters 2001, 301:159-162.
71. 2 purinoceptors. The Journal of General Physiology 1999, 113:695-720.
72. 1 receptor-evoked glutamate exocytosis from astrocytes: Control by tumor necrosis factor-α and prostaglandins. The Journal of Biological Chemistry 2006, 281:30684-30696.
73. 7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine. Epilepsy Research 2009, 83:157-167.
74. 7 receptor-mediated release of excitatory amino acids from astrocytes. The Journal of Neuroscience 2003, 23:1320-1328.
75. 2/3 receptor expression in rat sympathetic ganglion neurons. Developmental Dynamics 2005, 234:505-511.
76. 1 receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. Neuropharmacology 2000, 39:2054-2066.
77. 11 receptor. The Biochemical Journal 2008, 409:107-116.
78. Edwards F.A., Gibb A.J., Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature 1992, 359:144-147.
79. Edwards F.A., Robertson S.J., Gibb A.J. Properties of ATP receptor-mediated synaptic transmission in the rat medial habenula. Neuropharmacology 1997, 36:1253-1268.
80. Egan T.M., Khakh B.S. Contribution of calcium ions to P2X channel responses. The Journal of Neuroscience 2004, 24:3413-3420.
81. 1 receptor form disulfide bonds and are involved in receptor trafficking to the cell surface. Molecular Pharmacology 2002, 61:303-311.
82. Erb L., Liao Z., Seye C.I., Weisman G.A. P2 receptors: Intracellular signaling. Pflügers Archiv: European Journal of Physiology 2006, 452:552-562.
83. o -mediated signal transduction. The Journal of Cell Biology 2001, 153:491-501.
84. Erhardt A., Lucae S., Unschuld P.G., Ising M., Kern N., Salyakina D., et al. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. Journal of Affective Disorders 2007, 101:159-168.
85. Evans R.J., Lewis C., Virginio C., Lundstrom K., Buell G., Surprenant A., et al. Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. The Journal of Physiology 1996, 497:413-422.
86. 2+ signaling in astrocytes. The Journal of Neuroscience 2003, 23:4437-4444.
87. 2+ wave propagation in dorsal spinal cord astrocytes. The Journal of Neuroscience 2000, 20:2800-2808.
88. Fellin T., Pascual O., Haydon P.G. Astrocytes coordinate synaptic networks: Balanced excitation and inhibition. Physiology (Bethesda) 2006, 21:208-215.
89. Fellin T., Pozzan T., Carmignoto G. Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. The Journal of Biological Chemistry 2006, 281:4274-4284.
90. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Collo G., Buell G., et al. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 1997, 36:1295-1301.
91. 7 receptor: A key player in IL-1 processing and release. Journal of Immunology 2006, 176:3877-3883.
92. Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. The Journal of Biological Chemistry 1999, 274:13205-13210.
93. Fiacco T.A., Agulhon C., McCarthy K.D. Sorting out astrocyte physiology from pharmacology. Annual Review of Pharmacology and Toxicology 2009, 49:151-174.
94. Fields R.D., Stevens B. ATP: An extracellular signaling molecule between neurons and glia. Trends in Neurosciences 2000, 23:625-633.
95. + current in rat hippocampal pyramidal neurons. The Journal of Neuroscience 2006, 26:9340-9348.
96. 2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat. Neuroscience 2009, 160:767-783.
97. Fischer W., Krügel U. P2Y receptors: Focus on structural, pharmacological and functional aspects in the brain. Current Medicinal Chemistry 2007, 14:2429-2455.
98. 3 receptors are involved in agonist binding. European Journal of Pharmacology 2007, 576:7-17.
99. 2 purinergic receptors in precerebellar nuclei. Neuroscience 2002, 115:425-434.
100. Franke H., Grosche J., Schadlich H., Krügel U., Allgaier C., Illes P. P2X receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 2001, 108:421-429.
101. 7 receptor expression after ischemia in the cerebral cortex of rats. Journal of Neuropathology and Experimental Neurology 2004, 63:686-699.
102. Franke H., Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacology & Therapeutics 2006, 109:297-324.
103. 1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology 2003, 167:187-194.
104. Franke H., Krügel U., Schmidt R., Grosche J., Reichenbach A., Illes P. P2 receptor-types involved in astrogliosis in vivo. British Journal of Pharmacology 2001, 134:1180-1189.
105. Frenguelli B.G., Wigmore G., Llaudet E., Dale N. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. Journal of Neurochemistry 2007, 101:1400-1413.
106. 7 receptor antagonists and their potential for reducing central nervous system inflammation. Recent Patents on CNS Drug Discovery 2010, 5:35-45.
107. Fröhlich R., Boehm S., Illes P. Pharmacological characterization of P2 purinoceptor types in rat locus coeruleus neurons. European Journal of Pharmacology 1996, 315:255-261.
108. Fujii S., Kato H., Kuroda Y. Extracellular adenosine 5'-triphosphate plus activation of glutamatergic receptors induces long-term potentiation in CA1 neurons of guinea pig hippocampal slices. Neuroscience Letters 1999, 276:21-24.
109. 1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia 2009, 57:244-257.
110. 2 receptor channel. The Journal of Physiology 2004, 558:31-43.
111. Fumagalli M., Brambilla R., D'Ambrosi N., Volonté C., Matteoli M., Verderio C., et al. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia 2003, 43:218-230.
112. 2 receptors. The Journal of Neuroscience 2003, 23:6728-6739.
113. Gebicke-Haerter P.J., Wurster S., Schobert A., Hertting G. P2-purinoceptor induced prostaglandin synthesis in primary rat astrocyte cultures. Naunyn-Schmiedeberg's Archives of Pharmacology 1988, 338:704-707.
114. 7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. American Journal of Physiology. Cell Physiology 2003, 284:571-581.
115. Gerevich Z., Borvendeg S.J., Schröder W., Franke H., Wirkner K., Nörenberg W., et al. Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. The Journal of Neuroscience 2004, 24:797-807.
116. Gerevich Z., Illes P. P2Y receptors and pain transmission. Purinergic Signalling 2004, 1:3-10.
117. 3 receptor-channels in rat dorsal root ganglion neurons. European Journal of Pharmacology 2005, 521:34-38.
118. 3 receptors depends on the histidine 206 residue. The Journal of Biological Chemistry 2007, 282:33949-33957.
119. 3 receptor-channels via G protein-dependent facilitation of their desensitization. British Journal of Pharmacology 2007, 151:226-236.
120. Gever J.R., Cockayne D.A., Dillon M.P., Burnstock G., Ford A.P. Pharmacology of P2X channels. Pflügers Archiv: European Journal of Physiology 2006, 452:513-537.
121. Gomez-Villafuertes R., Gualix J., Miras-Portugal M.T. Single GABAergic synaptic terminals from rat midbrain exhibit functional P2X and dinucleotide receptors, able to induce GABA secretion. Journal of Neurochemistry 2001, 77:84-93.
122. Gourine A.V., Kasymov V., Marina N., Tang F., Figueiredo M.F., Lane S., et al. Astrocytes control breathing through pH-dependent release of ATP. Science 2010, 329:571-675.
123. Gu J.G., MacDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 1997, 389:749-753.
124. Gunosewoyo H., Kassiou M. P2X purinergic receptor ligands: Recently patented compounds. Expert Opinion on Therapeutic Patents 2010, 20:625-646.
125. 7 heteromeric receptors. Molecular Pharmacology 2007, 72:1447-1456.
126. Guthrie P.B., Knappenberger J., Segal M., Bennett M.V., Charles A.C., Kater S.B. ATP released from astrocytes mediates glial calcium waves. The Journal of Neuroscience 1999, 19:520-528.
127. 1 receptors inhibit long-term depression in the prefrontal cortex. Neuropharmacology 2010, 59:406-415.
128. Hamilton N.B., Attwell D. Do astrocytes really exocytose neurotransmitters?. Nature Reviews. Neuroscience 2010, 11:227-238.
129. 12 receptor regulates microglial activation by extracellular nucleotides. Nature Neuroscience 2006, 9:1512-1519.
130. Heine C., Wegner A., Grosche J., Allgaier C., Illes P., Franke H. P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience 2007, 149:165-181.
131. Hide I., Tanaka M., Inoue A., Nakajima K., Kohsaka S., Inoue K., et al. Extracellular ATP triggers tumor necrosis factor α release from rat microglia. Journal of Neurochemistry 2000, 75:965-972.
132. i/o -coupled P2Y receptors. The Journal of Neuroscience 2001, 21:1975-1982.
133. Hugel S., Schlichter R. Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons. The Journal of Neuroscience 2000, 20:2121-2130.
134. Hussl S., Boehm S. Functions of neuronal P2Y receptors. Pflügers Archiv: European Journal of Physiology 2006, 452:538-551.
135. 2+ via the phospholipase C/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord. Neuroscience 1998, 86:913-923.
136. 2+ mobilization in cultured rat spinal neurons. European Journal of Pharmacology 1996, 302:163-169.
137. 2+ release via a P2Y purinoceptor in hippocampal neurons. European Journal of Pharmacology 1996, 304:191-199.
138. Illes P., Nörenberg W., Gebicke-Haerter P.J. Molecular mechanisms of microglial activation. B. Voltage- and purinoceptor-operated channels in microglia. Neurochemistry International 1996, 29:13-24.
139. Illes P., Ribeiro J.A. Molecular physiology of P2 receptors in the central nervous system. European Journal of Pharmacology 2004, 483:5-17.
140. Inoue K. Purinergic systems in microglia. Cellular and Molecular Life Sciences 2008, 65:3074-3080.
141. 6 -evoked microglial phagocytosis. International Review of Neurobiology 2009, 85:159-163.
142. Jacobson K.A., Ivanov A.A., de Castro S., Harden T.K., Ko H. Development of selective agonists and antagonists of P2Y receptors. Purinergic Signalling 2009, 5:75-89.
143. 7 receptors stimulate AKT phosphorylation in astrocytes. British Journal of Pharmacology 2004, 141:1106-1117.
144. 2/3 antagonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters 2009, 19:1632-1635.
145. James G., Butt A.M. Changes in P2Y and P2X purinoceptors in reactive glia following axonal degeneration in the rat optic nerve. Neuroscience Letters 2001, 312:33-36.
146. 2+ signalling in glial cell pathology in the central nervous system. European Journal of Pharmacology 2002, 447:247-260.
147. Jameson H.S., Pinol R.A., Kamendi H., Mendelowitz D. ATP facilitates glutamatergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain Research 2008, 1201:88-92.
148. Jarvis M.F. The neural-glial purinergic receptor ensemble in chronic pain states. Trends in Neurosciences 2010, 33:48-57.
149. Jarvis M.F., Khakh B.S. ATP-gated P2X cation-channels. Neuropharmacology 2009, 56:208-215.
150. Jiang L.H., Kim M., Spelta V., Bo X., Surprenant A., North R.A. Subunit arrangement in P2X receptors. The Journal of Neuroscience 2003, 23:8903-8910.
151. Jimenez A.I., Castro E., Communi D., Boeynaems J.M., Delicado E.G., Miras-Portugal M.T. Coexpression of several types of metabotropic nucleotide receptors in single cerebellar astrocytes. Journal of Neurochemistry 2000, 75:2071-2079.
152. Jin Y.H., Bailey T.W., Li B.Y., Schild J.H., Andresen M.C. Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius. The Journal of Neuroscience 2004, 24:4709-4717.
153. John G.R., Scemes E., Suadicani S.O., Liu J.S., Charles P.C., Lee S.C., et al. IL-1β differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:11613-11618.
154. John G.R., Simpson J.E., Woodroofe M.N., Lee S.C., Brosnan C.F. Extracellular nucleotides differentially regulate interleukin-1β signaling in primary human astrocytes: Implications for inflammatory gene expression. The Journal of Neuroscience 2001, 21:4134-4142.
155. 6 receptors by N-linked glycosylation: Identification of a novel αβ-methylene ATP-sensitive phenotype. Molecular Pharmacology 2004, 65:979-985.
156. A receptor-mediated mechanism in the gerbil hippocampus. Brain Research. Molecular Brain Research 2003, 116:168-175.
157. 2 receptor subunit of the ATP-gated ion channels in the rat central nervous system. The Journal of Comparative Neurology 1999, 407:11-32.
158. 3 receptors can be explained by an allosteric two-open-state model. Molecular Pharmacology 2008, 73:224-234.
159. 1 receptors in the hippocampal slice. The Journal of Neuroscience 2004, 24:10835-10845.
160. 4 ion channel in the closed state. Nature 2009, 460:592-598.
161. Khakh B.S., Bao X.R., Labarca C., Lester H.A. Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nature Neuroscience 1999, 2:322-330.
162. 2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. The Journal of Neuroscience 2005, 25:6911-6920.
163. Khakh B.S., Henderson G. ATP receptor-mediated enhancement of fast excitatory neurotransmitter release in the brain. Molecular Pharmacology 1998, 54:372-378.
164. 4 receptor channels. The Journal of Neuroscience 1999, 19:7289-7299.
165. 2 -green fluorescent protein receptors. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:5288-5293.
166. 7 receptors. Purinergic Signalling 2010, 6:349-359.
167. Kim J.E., Kwak S.E., Jo S.M., Kang T.C. Blockade of P2X receptor prevents astroglial death in the dentate gyrus following pilocarpine-induced status epilepticus. Neurological Research 2009, 31:982-988.
168. 4 nucleotide receptors. Biochemical Pharmacology 2003, 65:923-931.
169. King B.F., Neary J.T., Zhu Q., Wang S., Norenberg M.D., Burnstock G. P2 purinoceptors in rat cortical astrocytes: Expression, calcium-imaging and signalling studies. Neuroscience 1996, 74:1187-1196.
170. 6 subunits in Xenopus oocytes. The Journal of Neuroscience 2000, 20:4871-4877.
171. 1 receptor-mediated nitric oxide production. Neuropsychopharmacology 2003, 28:435-444.
172. 1 receptors in rats: Modulation of feeding behaviour by extracellular nucleotides. The European Journal of Neuroscience 2006, 24:2049-2056.
173. 2 -like and by the blockade of ionotrophic glutamate receptors. Behavioural Brain Research 2004, 149:197-208.
174. Kittner H., Krügel U., Hoffmann E., Illes P. Modulation of feeding behaviour by blocking purinergic receptors in the rat nucleus accumbens: A combined microdialysis, electroencephalographic and behavioural study. The European Journal of Neuroscience 2004, 19:396-404.
175. Kittner H., Krügel U., Illes P. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats. Neuroscience 2001, 102:241-243.
176. Knutsen L.J.S., Murray T.F. Adenosine and ATP in epilepsy. Purinergic Approaches in Experimental Therapeutics 1997, 423-447. Wiley-Liss, New York. K.A. Jacobson, M.F. Jarvis (Eds.).
177. 12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. The Journal of Neuroscience 2008, 28:2892-2902.
178. Koch H., von Kügelgen I., Starke K. P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn-Schmiedeberg's Archives of Pharmacology 1997, 355:707-715.
179. Koizumi S., Fujishita K., Tsuda M., Shigemoto-Mogami Y., Inoue K. Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:11023-11028.
180. 6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095.
181. Köles L., Fürst S., Illes P. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. Drug News & Perspectives 2005, 18:85-101.
182. Köles L., Fürst S., Illes P. Purine ionotropic (P2X) receptors. Current Pharmaceutical Design 2007, 13:2368-2384.
183. Köles L., Gerevich Z., Oliveira J.F., Zadori Z.S., Wirkner K., Illes P. Interaction of P2 purinergic receptors with cellular macromolecules. Naunyn-Schmiedeberg's Archives of Pharmacology 2008, 377:1-33.
184. Koshimizu T.A., Kretschmannova K., He M.L., Ueno S., Tanoue A., Yanagihara N., et al. Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors. Molecular Pharmacology 2006, 69:1588-1598.
185. α16 and evidence for receptor oligomers. Cellular Signalling 2005, 17:869-880.
186. Krügel U., Kittner H., Franke H., Illes P. Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo. Neuropharmacology 2001, 40:1084-1093.
187. Krügel U., Kittner H., Franke H., Illes P. Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse 2003, 47:134-142.
188. Krügel U., Kittner H., Illes P. Adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Neuroscience Letters 1999, 265:49-52.
189. Krügel U., Kittner H., Illes P. Mechanisms of adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Synapse 2001, 39:222-232.
190. Kucher B.M., Neary J.T. Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-α release in lipopolysaccharide-stimulated astrocytes. Journal of Neurochemistry 2005, 92:525-535.
191. 2 receptor and TRPV channel by ATP: Implications for ATP induced pain. Cellular and Molecular Neurobiology 2005, 25:819-832.
192. 5 subunits form the functional P2X receptor in mouse cortical astrocytes. The Journal of Neuroscience 2008, 28:5473-5480.
193. Lazarowski E.R., Boucher R.C., Harden T.K. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. The Journal of Biological Chemistry 2000, 275:31061-31068.
194. 7 receptors in ischemic and excitotoxic brain injury in vivo. Journal of Cerebral Blood Flow and Metabolism 2003, 23:381-384.
195. 6 channel subunits coassemble into a novel heteromeric ATP receptor. The Journal of Neuroscience 1998, 18:7152-7159.
196. Lecca D., Trincavelli M.L., Gelosa P., Sironi L., Ciana P., Fumagalli M., et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One 2008, 3:e3579.
197. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 1995, 377:432-435.
198. Li J., Perl E.R. ATP modulation of synaptic transmission in the spinal substantia gelatinosa. The Journal of Neuroscience 1995, 15:3357-3365.
199. Liu J.S., John G.R., Sikora A., Lee S.C., Brosnan C.F. Modulation of interleukin-1β and tumor necrosis factor α signaling by P2 purinergic receptors in human fetal astrocytes. The Journal of Neuroscience 2000, 20:5292-5299.
200. 7 receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms. Journal of Neurochemistry 2008, 105:151-164.
201. 1 receptors in rat cerebellum. Cell and Tissue Research 1998, 294:253-260.
202. 7 receptors mediate NADH transport across the plasma membranes of astrocytes. Biochemical and Biophysical Research Communications 2007, 362:946-950.
203. Lucae S., Salyakina D., Barden N., Harvey M., Gagné B., Labbé M., et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Human Molecular Genetics 2006, 15:2438-2445.
204. 1 receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex. Neurochemistry International 2003, 42:161-172.
205. q -coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Molecular Pain 2010, 6:21.
206. 7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. The Journal of Neuroscience 2007, 27:9525-9533.
207. 7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus. Journal of Neuropathology and Experimental Neurology 2006, 65:1090-1097.
208. Mendoza-Fernández V., Andrew R.D., Barajas-López C. ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. The Journal of Pharmacology and Experimental Therapeutics 2000, 293:172-179.
209. 7 R pore. The Journal of Neuroscience 2009, 29:3781-3791.
210. Moore D.J., Chambers J.K., Wahlin J.P., Tan K.B., Moore G.B., Jenkins O., et al. Expression pattern of human P2Y receptor subtypes: A quantitative reverse transcription-polymerase chain reaction study. Biochimica et Biophysica Acta 2001, 1521:107-119.
211. i/o -coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: Possible role in neuroimmune function. Brain Research. Molecular Brain Research 2003, 118:10-23.
212. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain Research. Molecular Brain Research 2000, 78:50-58.
213. Mori M., Heuss C., Gahwiler B.H., Gerber U. Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. The Journal of Physiology 2001, 535:115-123.
214. 2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. The Journal of Neuroscience 2003, 23:6058-6062.
215. Murakami K., Nakamura Y., Yoneda Y. Potentiation by ATP of lipopolysaccharide-stimulated nitric oxide production in cultured astrocytes. Neuroscience 2003, 117:37-42.
216. Nakatsuka T., Gu J.G. ATP P2X receptor-mediated enhancement of glutamate release and evoked EPSCs in dorsal horn neurons of the rat spinal cord. The Journal of Neuroscience 2001, 21:6522-6531.
217. Nakazawa K. ATP-activated current and its interaction with acetylcholine-activated current in rat sympathetic neurons. The Journal of Neuroscience 1994, 14:740-750.
218. + current in cultured rat hippocampal neurons. Pflügers Archiv: European Journal of Physiology 1994, 429:143-145.
219. 2 receptor. European Journal of Pharmacology 2005, 518:107-110.
220. Neary J.T., Kang Y., Bu Y., Yu E., Akong K., Peters C.M. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. The Journal of Neuroscience 1999, 19:4211-4220.
221. Newbolt A., Stoop R., Virginio C., Surprenant A., North R.A., Buell G., et al. Membrane topology of an ATP-gated ion channel (P2X receptor). The Journal of Biological Chemistry 1998, 273:15177-15182.
222. Newman E.A. New roles for astrocytes: Regulation of synaptic transmission. Trends in Neurosciences 2003, 26:536-542.
223. 3 receptors form stable trimers: A novel structural motif of ligand-gated ion channels. The EMBO Journal 1998, 17:3016-3028.
224. 4 subunits. Journal of Neurochemistry 2005, 92:925-933.
225. Nieber K., Poelchen W., Illes P. Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. British Journal of Pharmacology 1997, 122:423-430.
226. Nörenberg W., Illes P. Neuronal P2X receptors: Localisation and functional properties. Naunyn-Schmiedeberg's Archives of Pharmacology 2000, 362:324-339.
227. 7 receptors in rat cultured neocortical astroglia. British Journal of Pharmacology 2010, 160:1941-1952.
228. North R.A. P2X receptors: A third major class of ligand-gated ion channels. Ciba Foundation Symposium 1996, 198:91-105.
229. North R.A. Molecular physiology of P2X receptors. Physiological Reviews 2002, 82:1013-1067.
230. 7 receptors sensing pathologically high ATP concentrations. Cereb Cortex 2011, 21:806-820.
231. Pankratov Y., Castro E., Miras-Portugal M.T., Krishtal O. A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus. The European Journal of Neuroscience 1998, 10:3898-3902.
232. Pankratov Y., Lalo U., Krishtal O., Verkhratsky A. Ionotropic P2X purinoreceptors mediate synaptic transmission in rat pyramidal neurones of layer II/III of somato-sensory cortex. The Journal of Physiology 2002, 542:529-536.
233. Pankratov Y., Lalo U., Krishtal O.A., Verkhratsky A. P2X receptors and synaptic plasticity. Neuroscience 2009, 158:137-148.
234. Pankratov Y., Lalo U., Verkhratsky A., North R.A. Quantal release of ATP in mouse cortex. The Journal of General Physiology 2007, 129:257-265.
235. Papp L., Balázsa T., Köfalvi A., Erdélyi F., Szabó G., Vizi E.S., et al. P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices. The Journal of Pharmacology and Experimental Therapeutics 2004, 310:973-980.
236. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. The Journal of Biological Chemistry 2003, 278:13309-13317.
237. 7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals. Neuropharmacology 2006, 50:705-713.
238. 3 subunit. The Journal of Biological Chemistry 2001, 276:21077-21082.
239. 2+ mobilisation and prostanoid release from astrocytes: P2-purinergic receptors linked to phosphoinositide hydrolysis. Journal of Neurochemistry 1989, 52:971-977.
240. Price G.D., Robertson S.J., Edwards F.A. Long-term potentiation of glutamatergic synaptic transmission induced by activation of presynaptic P2Y receptors in the rat medial habenula nucleus. The European Journal of Neuroscience 2003, 17:844-850.
241. 4 receptors by lysosomal targeting, glycan protection and exocytosis. Journal of Cell Science 2007, 120:3838-3849.
242. 3 receptors. The Journal of Neuroscience 1997, 17:6529-6533.
243. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacological Reviews 1998, 50:413-492.
244. 7 receptor modulation of β-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. Journal of Neuroimmunology 2004, 147:56-61.
245. 7 ATP receptors following LPS-induced activation. Neuropharmacology 2007, 53:496-504.
246. 7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Research 2006, 1089:171-178.
247. 1 receptor. The Journal of Biological Chemistry 2000, 275:33542-33547.
248. Rhee J.S., Wang Z.M., Nabekura J., Inoue K., Akaike N. ATP facilitates spontaneous glycinergic IPSC frequency at dissociated rat dorsal horn interneuron synapses. The Journal of Physiology 2000, 524:471-483.
249. 7 receptor-operated single channels currents. Biophysical Journal 2007, 92:2377-2391.
250. Roberts J.A., Vial C., Digby H.R., Agboh K.C., Wen H., Atterbury-Thomas A., et al. Molecular properties of P2X receptors. Pflügers Archiv: European Journal of Physiology 2006, 452:486-500.
251. Robertson S.J., Ennion S.J., Evans R.J., Edwards F.A. Synaptic P2X receptors. Current Opinion in Neurobiology 2001, 11:378-386.
252. 4 receptors in the rat hippocampus. The Journal of Neuroscience 2005, 25:6286-6295.
253. Royle S.J., Bobanovic L.K., Murrell-Lagnado R.D. Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor. The Journal of Biological Chemistry 2002, 277:35378-35385.
254. 2+ in cultured rat striatal neurons. Neurochemistry International 2008, 52:113-118.
255. 1 receptors may depend on the developmental stage of cultured rat striatal neurons. Journal of Cellular Physiology 2006, 209:81-93.
256. Rubio M.E., Soto F. Distinct localization of P2X receptors at excitatory postsynaptic specializations. The Journal of Neuroscience 2001, 21:641-653.
257. Saitow F., Murakoshi T., Suzuki H., Konishi S. Metabotropic P2Y purinoceptor-mediated presynaptic and postsynaptic enhancement of cerebellar GABAergic transmission. The Journal of Neuroscience 2005, 25:2108-2116.
258. Salter M.W., Hicks J.L. ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord. The Journal of Neuroscience 1994, 14:1563-1575.
259. 12 in microglia in rat brain. Glia 2003, 44:242-250.
260. 12 receptor oligomers and partitions them out of lipid rafts. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:11069-11074.
261. 2+ entry through presynaptic P2X receptors elicits postsynaptic firing in the brainstem autonomic network. The Journal of Neuroscience 2004, 24:3125-3135.
262. 4 receptors. PLoS Biology 2009, 7:e103.
263. 4 knock-out mice. The Journal of Neuroscience 2006, 26:9006-9009.
264. 7 receptor expression in rodent brain. The Journal of Neuroscience 2004, 24:6307-6314.
265. 35 S]dATPαS binding sites in the adult rat neuraxis. Neuropharmacology 1997, 36:1243-1251.
266. 7 purinergic receptor: From physiology to neurological disorders. The FASEB Journal 2010, 24:337-345.
267. 2 receptor C-terminus that regulate desensitization. The Journal of Physiology 1999, 520:91-99.
268. Sokolova E., Nistri A., Giniatullin R. Negative cross talk between anionic GABAA and cationic P2X ionotropic receptors of rat dorsal root ganglion neurons. The Journal of Neuroscience 2001, 21:4958-4968.
269. 3 receptors provides a novel and sensitive approach for their rapid up or downregulation. British Journal of Pharmacology 2004, 141:1048-1058.
270. 3 receptors. Nature 2000, 407:1015-1017.
271. (3) H]-noradrenaline release from the isolated guinea-pig right atrium by P2X-receptors located on axon terminals. British Journal of Pharmacology 2000, 131:1775-1783.
272. Sperlágh B., Heinrich A., Csölle C. P2 receptor-mediated modulation of neurotransmitter release-An update. Purinergic Signalling 2007, 3:269-284.
273. 7 receptors in the regulation of neurotransmitter release in the rat hippocampus. Journal of Neurochemistry 2002, 81:1196-1211.
274. Sperlágh B., Vizi E.S. Effect of presynaptic P2 receptor stimulation on transmitter release. Journal of Neurochemistry 1991, 56:1466-1470.
275. 7 receptors in the nervous system. Progress in Neurobiology 2006, 78:327-346.
276. 3 receptors. Pain 2009, 143:26-36.
277. 3 receptors after substitution by Asp of Ser/Thr residues in protein kinase C phosphorylation sites of their ecto-domains. Neuroscience Letters 2006, 393:78-83.
278. Stella N., Estelles A., Siciliano J., Tencé M., Desagher S., Piomelli D., et al. Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. The Journal of Neuroscience 1997, 17:2939-2946.
279. Stout C.E., Costantin J.L., Naus C.C., Charles A.C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. The Journal of Biological Chemistry 2002, 277:10482-10488.
280. 2+ signaling. The Journal of Neuroscience 2006, 26:1378-1385.
281. 2 receptor in mouse pineal gland tumor cells. Journal of Neurochemistry 2001, 77:1475-1485.
282. 7 receptor-activated microglia. The Journal of Neuroscience 2004, 24:1-7.
283. 2 receptor. Biochemical and Biophysical Research Communications 2006, 351:559-565.
284. Tominaga M., Wada M., Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6951-6956.
285. 1 purine receptors in rat hippocampus. The European Journal of Neuroscience 2007, 26:890-902.
286. Torres G.E., Egan T.M., Voigt M.M. Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. The Journal of Biological Chemistry 1999, 274:6653-6659.
287. 5 receptor subunits reveals a novel ATP-gated ion channel. Molecular Pharmacology 1998, 54:989-993.
288. 4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Molecular Pharmacology 2006, 69:576-587.
289. 12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. The Journal of Neuroscience 2008, 28:4949-4956.
290. Trendelenburg A.U., Bültmann R. P2 receptor-mediated inhibition of dopamine release in rat neostriatum. Neuroscience 2000, 96:249-252.
291. Tsuda M., Inoue K., Salter M.W. Neuropathic pain and spinal microglia: A big problem from molecules in "small" glia. Trends in Neurosciences 2005, 28:101-107.
292. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783.
293. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A., et al. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 1994, 371:516-519.
294. 12 receptor stimulation inhibits β-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B. Journal of Neurochemistry 2004, 89:442-453.
295. Verkhratsky A., Krishtal O.A., Burnstock G. Purinoceptors on neuroglia. Molecular Neurobiology 2009, 39:190-208.
296. 1 receptors does not involve direct channel phosphorylation. The Biochemical Journal 2004, 382:101-110.
297. Vianna E.P., Ferreira A.T., Naffah-Mazzacoratti M.G., Sanabria E.R., Funke M., Cavalheiro E.A., et al. Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: Fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 2002, 5:227-229.
298. 7 receptor. Neuropharmacology 1997, 36:1285-1294.
299. Virginio C., MacKenzie A., Rassendren F.A., North R.A., Surprenant A. Pore dilation of neuronal P2X receptor channels. Nature Neuroscience 1999, 2:315-321.
300. Vizi E.S., Knoll J. The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine. Neuroscience 1976, 1:391-398.
301. Volonte C., Amadio S., Cavaliere F., D'Ambrosi N., Vacca F., Bernardi G. Extracellular ATP and neurodegeneration. Current Drug Targets. CNS and Neurological Disorders 2003, 2:403-412.
302. Volonte C., Amadio S., D'Ambrosi N., Colpi M., Burnstock G. P2 receptor web: Complexity and fine-tuning. Pharmacology & Therapeutics 2006, 112:264-280.
303. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacology & Therapeutics 2006, 110:415-432.
304. von Kügelgen I., Koch H., Starke K. P2-receptor-mediated inhibition of serotonin release in the rat brain cortex. Neuropharmacology 1997, 36:1221-1227.
305. von Kügelgen I., Schöffel E., Starke K. Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Archives of Pharmacology 1989, 340:522-532.
306. von Kügelgen I., Späth L., Starke K. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. British Journal of Pharmacology 1994, 113:815-822.
307. 3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology 1997, 36:1229-1242.
308. Wakamori M., Sorimachi M. Properties of nativenaive P2X receptors in large multipolar neurons dissociated from rat hypothalamic arcuate nucleus. Brain Research 2004, 1005:51-59.
309. Walter L., Dinh T., Stella N. ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. The Journal of Neuroscience 2004, 24:8068-8074.
310. Wang Y., Haughey N.J., Mattson M.P., Furukawa K. Dual effects of ATP on rat hippocampal synaptic plasticity. NeuroReport 2004, 15:633-636.
311. Wang L., Karlsson L., Moses S., Hultgårdh-Nilsson A., Andersson M., Borna C., et al. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. Journal of Cardiovascular Pharmacology 2002, 40:841-853.
312. Wang Z.M., Katsurabayashi S., Rhee J.S., Brodwick M., Akaike N. Substance P abolishes the facilitatory effect of ATP on spontaneous glycine release in neurons of the trigeminal nucleus pars caudalis. The Journal of Neuroscience 2001, 21:2983-2991.
313. Watano T., Calvert J.A., Vial C., Forsythe I.D., Evans R.J. P2X receptor subtype-specific modulation of excitatory and inhibitory synaptic inputs in the rat brainstem. The Journal of Physiology 2004, 558:745-757.
314. Westfall D.P., Shinozuka K., Forsyth K.M., Bjur R.A. Presynaptic purine receptors. Annals of the New York Academy of Sciences 1990, 604:130-135.
315. 11 receptors: Evidence for agonist-specific signaling. Molecular Pharmacology 2003, 63:1356-1363.
316. Wirkner K., Günther A., Weber M., Guzman S.J., Krause T., Fuchs J., et al. Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation. Cerebral Cortex 2007, 17:621-631.
317. Wirkner K., Köles L., Thümmler S., Luthardt J., Poelchen W., Franke H., et al. Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex. Neuropharmacology 2002, 42:476-488.
318. 3 receptor involvement in pain states. Molecular Neurobiology 2007, 36:165-183.
319. 3 receptors by ecto-protein kinase C. The Journal of Neuroscience 2005, 25:7734-7742.
320. 7 receptors control 2-arachidonoylglycerol production by microglial cells. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3214-3219.
321. 2+ release enhances neuroprotection by increasing astrocyte mitochondrial metabolism during aging. The Journal of Neuroscience 2007, 27:6510-6520.
322. Yamakuni H., Kawaguchi N., Ohtani Y., Nakamura J., Katayama T., Nakagawa T., et al. ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. Journal of Neuroimmunology 2002, 129:43-50.
323. 1 receptors in rat brains. FEBS Letters 2002, 531:299-303.
324. Yoshioka K., Saitoh O., Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:7617-7622.
325. Young M.T. P2X receptors: Dawn of the post-structure era. Trends in Biochemical Sciences 2010, 35:83-90.
326. 1 receptor in astroglia-to-neuron signaling at dorsal spinal cord. Journal of Neuroscience Research 2009, 87:2667-2676.
327. Zhang Z., Chen G., Zhou W., Song A., Xu T., Luo Q., et al. Regulated ATP release from astrocytes through lysosome exocytosis. Nature Cell Biology 2007, 9:945-953.
328. Zhang Y.X., Yamashita H., Ohshita T., Sawamoto N., Nakamura S. ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum. Brain Research 1995, 691:205-212.
329. 7 receptor in generation of tolerance to morphine analgesia in rats. The Journal of Neuroscience 2010, 30:8042-8047.
330. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Foundation Symposium 2006, 276:113-128.